People

Rolf Barth

  • Professor of Surgery
  • Research and Scholarly Interests: Immune Tolerance, Liver, Kidney, and Pancreas Transplantation, Living organ donation, Vascularized Composite Allotransplantation, Xenotransplantation
  • Websites: Research Network Profile
  • Contact: rbarth1@uchicago.edu

Dr. Barth serves as the Director of Liver Transplantation and Associate Director of The University of Chicago Medicine Transplant Institute. His clinical practice focuses on kidney, pancreas, and liver transplant with specific accomplishments in living donor kidney and liver transplantation. Dr. Barth has pioneered minimally invasive surgery for living kidney donation and developed and has performed over 500 ‘scarless,’ single-port laparoscopic donor nephrectomies.



Dr. Barth has active clinical and basic research interests that include novel immunosuppressive therapies, immunologic tolerance, and the use of genetically engineered animal organs for human transplantation (xenotransplantation). Dr. Barth led an active lab investigating transplant tolerance and pre-clinical models of composite facial and limb transplantation, toward the clinical goal of reconstructive transplantation.

University of Wisconsin
- Transplant Surgery Fellowship
2006

Duke University
- General Surgery Residency
2004

Mass. General Hosp/Harvard Medical School
- Transplant Immunology Fellowship
2001

Duke University
MD - Medical Degree
1997

Emphysematous Gastritis in a Transplant Recipient With Clostridium ventriculi Infection.
St Michel DP, Borth A, Rubin J, Goussous N, Twaddell W, Malik S, Barth R. Emphysematous Gastritis in a Transplant Recipient With Clostridium ventriculi Infection. ACG Case Rep J. 2020 Dec; 7(12):e00488.
PMID: 33324709

The Demise of Islet Allotransplantation in the US: A Call for an Urgent Regulatory Update The "ISLETS FOR US" Collaborative.
Witkowski P, Philipson L, Kaufman DB, Ratner L, Abouljoud MS, Bellin M, Buse J, Kandeel F, Stock P, Mulligan D, Markmann JF, Kozlowski T, Andreoni K, Alejandro R, Baidal D, Hardy MA, Wickrema A, Mirmira RG, Fung J, Becker Y, Josephson MA, Bachul PJ, Pyda JS, Charlton M, Millis JM, Gaglia J, Stratta RJ, Fridell JA, Niederhaus S, Forbes RC, Jayant K, Robertson RP, Odorico J, Levy M, Harland R, Abrams PL, Olaitan OK, Kandaswamy R, Wellen J, Japour AJ, Desai CS, Naziruddin B, Balamurugan AN, Barth RN, Ricordi C. The Demise of Islet Allotransplantation in the US: A Call for an Urgent Regulatory Update The "ISLETS FOR US" Collaborative. Am J Transplant. 2020 Nov 29.
PMID: 33251712

Is Prophylactic Drainage After Pancreas Transplant Associated With Reduced Reoperation Rate?
Goussous N, St Michel DP, Mcdade H, Gaines S, Borth A, Dawany N, Al-Qaoud T, Bromberg JS, Barth RN, Scalea JR. Is Prophylactic Drainage After Pancreas Transplant Associated With Reduced Reoperation Rate? Exp Clin Transplant. 2020 Nov 27.
PMID: 33272163

Financial incentives versus standard of care to improve patient compliance with live kidney donor follow-up: protocol for a multi-center, parallel-group randomized controlled trial.
Levan ML, Waldram MM, DiBrito SR, Thomas AG, Al Ammary F, Ottman S, Bannon J, Brennan DC, Massie AB, Scalea J, Barth RN, Segev DL, Garonzik-Wang JM. Financial incentives versus standard of care to improve patient compliance with live kidney donor follow-up: protocol for a multi-center, parallel-group randomized controlled trial. BMC Nephrol. 2020 Nov 09; 21(1):465.
PMID: 33167882

Treatment of Renin-Angiotensin-Aldosterone System Dysfunction With Angiotensin II in High-Renin Septic Shock.
Chow JH, Wallis M, Lankford AS, Chancer Z, Barth RN, Scalea JR, LaMattina JC, Mazzeffi MA, McCurdy MT. Treatment of Renin-Angiotensin-Aldosterone System Dysfunction With Angiotensin II in High-Renin Septic Shock. Semin Cardiothorac Vasc Anesth. 2020 Aug 12; 1089253220949070.
PMID: 32787515

Multiple Regional Listing Increases Liver Transplant Rates for Those With Model for End-stage Liver Disease Score <15.
Brown S, Savva Y, Barth R, LaMattina J, Thuluvath PJ. Multiple Regional Listing Increases Liver Transplant Rates for Those With Model for End-stage Liver Disease Score <15. Transplantation. 2020 04; 104(4):762-769.
PMID: 31568393

Hepatic Artery Pseudoaneurysm in the Liver Transplant Recipient: A Case Series.
St Michel DP, Goussous N, Orr NL, Barth RN, Gray SH, LaMattina JC, Bruno DA. Hepatic Artery Pseudoaneurysm in the Liver Transplant Recipient: A Case Series. Case Rep Transplant. 2019; 2019:9108903.
PMID: 31976118

How to Help Patients Considering VCA.
Benedict JL, Barth RN. How to Help Patients Considering VCA. AMA J Ethics. 2019 11 01; 21(11):E960-967.
PMID: 31742544

Successful Implementation of Unmanned Aircraft Use for Delivery of a Human Organ for Transplantation.
Scalea JR, Pucciarella T, Talaie T, Restaino S, Drachenberg CB, Alexander C, Qaoud TA, Barth RN, Wereley NM, Scassero M. Successful Implementation of Unmanned Aircraft Use for Delivery of a Human Organ for Transplantation. Ann Surg. 2019 Oct 28.
PMID: 31663974

Assessing Pancreas Transplant Candidate Cardiac Disease: Preoperative Protocol Development at a Rapidly Growing Transplant Program.
St Michel D, Donnelly T, Jackson T, Taylor B, Barth RN, Bromberg JS, Scalea JR. Assessing Pancreas Transplant Candidate Cardiac Disease: Preoperative Protocol Development at a Rapidly Growing Transplant Program. Methods Protoc. 2019 Oct 17; 2(4).
PMID: 31627355

View All Publications